MYGN logo Myriad Genetics : MYGN

MYGN

Stock Data

$4.80

Change up

$0.05 (1.05%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

DIAGNOSTICS & RESEARCH

Myriad Genetics Inc is a pioneer in genetic testing and precision medicine, offering a wide range of molecular diagnostic tests. These tests are crucial in the fields of oncology, women's health, and pharmacogenomics, helping to assess risks for hereditary cancers and guide therapy decisions for various cancers including breast, ovarian, and prostate. Additionally, Myriad Genetics provides tests for prenatal screening and mental health medication guidance, collaborating with notable institutions like Illumina and Memorial Sloan Kettering Cancer Center. Founded in 1992, the company is based in Salt Lake City, Utah.

All Myriad Genetics Articles

85 Articles

1 2 3 6

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.